Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$29.28 -0.57 (-1.91%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Total Liabilities (2021 - 2026)

Updated

Amylyx Pharmaceuticals' Total Liabilities came in at $25.4 million for Q2 2026, down 5.0% from $26.72 million a year earlier but up 24.2% from the prior quarter.

Analysis

Amylyx Pharmaceuticals (AMLX) Total Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2025, Amylyx Pharmaceuticals' Total Liabilities was $27.39 million, down 5.1% from FY2024.

  • Total Liabilities carries a four-year compound annual growth rate of -42.9% (FY2021 to FY2025).
  • Going back by year, Total Liabilities was $28.87 million in FY2024 (-65.6%), $84.02 million in FY2023 (+65.2%), $50.85 million in FY2022 (-80.2%) and $256.78 million in FY2021.
  • The five-year range for quarterly Total Liabilities is $18.26 million (Q1 2025) to $256.78 million (Q4 2021).
  • Year-over-year, Total Liabilities increased in two of the last eight quarters, with an average decline of 29.6%.
  • The fastest year-over-year change in Total Liabilities over five years came in Q2 2023 (growth of 107.2%), and the weakest in Q1 2025 (a decline of 80.4%).
  • Business Quant data shows AMLX's Total Liabilities at $20.44 million (Q1 2026), $27.39 million (Q4 2025) and $30.75 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Amylyx Pharmaceuticals 3.32 Bn 3.32 Bn - 25.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.40 Mn
Mar 31, 2026 20.44 Mn
Dec 31, 2025 27.39 Mn
Sep 30, 2025 30.75 Mn
Jun 30, 2025 26.72 Mn
Mar 31, 2025 18.26 Mn
Dec 31, 2024 28.87 Mn
Sep 30, 2024 54.51 Mn
Jun 30, 2024 70.85 Mn
Mar 31, 2024 93.02 Mn
Dec 31, 2023 84.02 Mn
Sep 30, 2023 48.18 Mn
Jun 30, 2023 67.22 Mn
Mar 31, 2023 55.31 Mn
Dec 31, 2022 50.85 Mn
Sep 30, 2022 37.42 Mn
Jun 30, 2022 32.45 Mn
Mar 31, 2022 33.49 Mn
Dec 31, 2021 256.78 Mn
API Access

Amylyx Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=AMLX&period=max&api_key=YOUR_API_KEY